Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2024 Mar 4;206(3):e00365-23. doi: 10.1128/jb.00365-23

Flip the switch: the role of FleQ in modulating the transition between the free-living and sessile mode of growth in Pseudomonas aeruginosa

Victoria I Oladosu 1, Soyoung Park 2, Karin Sauer 1,
Editor: Michael Y Galperin3
PMCID: PMC10955856  PMID: 38436566

ABSTRACT

Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen causing chronic infections that are associated with the sessile/biofilm mode of growth rather than the free-living/planktonic mode of growth. The transcriptional regulator FleQ contributes to both modes of growth by functioning both as an activator and repressor and inversely regulating flagella genes associated with the planktonic mode of growth and genes contributing to the biofilm mode of growth. Here, we review findings that enhance our understanding of the molecular mechanism by which FleQ enables the transition between the two modes of growth. We also explore recent advances in the mechanism of action of FleQ to both activate and repress gene expression from a single promoter. Emphasis will be on the role of sigma factors, cyclic di-GMP, and the transcriptional regulator AmrZ in inversely regulating flagella and biofilm-associated genes and converting FleQ from a repressor to an activator.

KEYWORDS: FleQ, AmrZ, bofilm, flagella, Pel polysaccharide, Psl polysaccharide, alginate, AlgT, c-di-GMP, FleN

INTRODUCTION

The opportunistic human pathogen Pseudomonas aeruginosa has been linked to a variety of chronic infections, including chronic lung infections in individuals with cystic fibrosis (CF), community-acquired pneumonia, burn wounds, chronic catheter-associated infections, foot ulcers, and corneal and mechanical ventilation-related infections (19). P. aeruginosa has been estimated to cause over 51,000 infections annually (10), with 32,600 infections among hospitalized patients (10) and 2,700 estimated deaths in the United States alone (10). Worldwide, this pathogen has been attributed to 10%–15% of nosocomial infections and more than 500,000 deaths, highlighting its negative impact on public health (7, 1013).

It is now well established that bacteria display two different types of lifestyles: the planktonic, free-living mode of growth that is associated with acute infections and increased vulnerability to antimicrobial agents (1418), and the sessile mode of growth, characterized by bacteria growing in surface-associated or non-adherent aggregates of cells enclosed in a self-produced exopolysaccharide matrix. The sessile or biofilm mode of growth is grossly associated with chronic infections (19). Not surprisingly, the chronicity of these infections has been attributed to P. aeruginosa growing in these sessile biofilm communities (20).

Chronic infections are associated with the sessile mode of growth due to the heightened tolerance of biofilm cells, relative to planktonic cells, to antimicrobial agents and the host immune response (3, 16, 18, 21, 22). This characteristic is a trade-off, with biofilm cells experiencing high cell density (23), reduced metabolic rates (14, 24, 25), reduced growth rates/dormancy (14, 24, 26), and nutrient limitation (27) relative to the free-living lifestyle. Additionally, biofilm cells are characterized by increased production of extracellular polymeric matrix (28, 29) with the matrix contributing to sequestration of both nutrients and xenobiotics (27).

Despite (or because of) this trade-off, the sessile mode of growth is considered the most prevalent and predominant mode of bacterial growth (30, 31). In P. aeruginosa, the transition between these two modes of growth is highly regulated (3234) and coincides with the inverse regulation of genes encoding flagella and matrix components, including exopolysaccharide (Pel, Psl, and alginate) and adhesins (CdrAB) (3543). Regulators controlling the expression of the aforementioned genes include the GacS/GacA two-component regulatory system (TCS), BfiS/BfiR TCS, RsmA, and SagS to mention a few, which have been reviewed previously (33, 44, 45). Among these regulatory proteins, FleQ stands out by inversely regulating genes encoding flagella and exopolysaccharides in a manner dependent on two sigma factors and the secondary messenger cyclic di-GMP (c-di-GMP). More importantly, FleQ is considered to play a central role in mediating the transition between planktonic and biofilm lifestyles (36), with its role not being limited to P. aeruginosa but extending to other Pseudomonas species, including Pseudomonas putida (46, 47), Pseudomonas fluorescens (4749), and Pseudomonas syringae (50). The goal of this review is to provide an overview of the mechanisms by which FleQ contributes to the transition between these two modes of growth. We also explore how FleQ affects the inverse regulation of motility and matrix production.

FleQ AND THE HIERARCHICAL REGULATION OF THE EXPRESSION OF FLAGELLAR GENES

FleQ was first reported by Arora and colleagues in 1997 (51) as a transcriptional activator that, similar to FleR (51), is involved in the regulation of flagellar gene expression in P. aeruginosa. Flagellar biogenesis in P. aeruginosa involves more than 40 genes, many of which are positively regulated by FleQ (51). These include flhA and fliLMNOPQRflhB, which are involved in flagellar export; flhF, which is involved in the localization of the flagellar apparatus; fleSR, a two-component sensor and regulator involved in flagellin synthesis; flgFGHIJKL and flgBCDE operons which encodes the hook basal body (HBB); fliEFGHIJ, which encodes the flagellar basal body MS ring and motor switch complex; fliDS, which encodes the flagellar cap and export proteins; and flgA, which encodes the basal body P-ring protein (Fig. 1; Table 1).

Fig 1.

Fig 1

Flagella structural proteins and hierarchical regulation of flagella-associated genes in Pseudomonas species. (A) Location of flagella proteins in assembled flagella complex and order of assembly (Class I–IV indicate the order of the assembly). The protein export apparatus is composed of a transmembrane export gate complex (indicated as an Export gate). Components contributing to the C, MS, P, and L-ring are color-coded. OM, outer membrane; PG, peptidoglycan; IM, inner membrane. (B) Hierarchical expression of flagella genes. The cascade is initiated by FleQ, with fleQ expression being dependent on σ70. FleQ activates class II genes including fleSR in a σ54-dependent manner. FleR, in turn, regulates class III genes encoding components of the HBB in a σ54-dependent manner. Class IV genes are expressed in a FliA-dependent manner. The sigma factor FliA is sequestered by FlgM. Once the HBB is assembled, FlgM is exported, freeing FliA to enable the expression of class IV genes encoding the, e.g., flagellin filament (fliC) and flagellin cap (fliD). Moreover, FliK is exported during hook assembly and acts as a ruler to measure the hook length. When the hook length reaches about 55 nm, the export of FlgE and FliK is terminated, and the export of filament-type export substrates, such as FlgK, FlgL, FliC, and FliD, is initiated. Genes highlighted in yellow belong to both class II (directly regulated by FleQ) and IV [as the export of these gene products is dependent on the assembly of the HBB (52)]. The regulation of FliA for these genes is unknown.

TABLE 1.

Summary of P. aeruginosa genes directly regulated by FleQ and their expression under varying levels of intracellular c-di-GMP

Gene Function FleQ-dependent regulation References
Low c-di-GMP High c-di-GMP
fleN Anti-activator of FleQ Unknown Unknown 52 55
fleS Two-component sensor kinase Activated Repressed 5254, 56
fleR Two-component response regulator Activated Repressed 5254, 56
fliD Flagellin cap protein Activated Repressed 52, 53
fliE Rod adaptor protein Activated Repressed 52, 53
fliF MS-ring protein Activated Repressed 52, 53
fliG C-ring protein Activated Repressed 52, 53
fliHIJ ATPase complex Activated Repressed 52, 53
fliL Flagellum-associated protein Activated Repressed 52, 53
fliMN C-ring proteins Activated Repressed 52, 53, 56
fliOPQR Export gate proteins Activated Repressed 52, 53
fliS Flagellin chaperone protein Activated Repressed 52, 53
flhF Polar landmark protein Activated Repressed 52, 53
flgA Flagella basal body P-ring formation protein Activated Repressed 52, 53
flgZ C-di-GMP effector Activated Repressed 52
fliT Flagellin cap chaperone protein Activated Repressed 52
fleP Flagellin cap chaperone protein Activated Repressed 52, 53
flgM Anti-sigma 28 factor Activated Repressed 52, 53
flgN Hook-filament junction chaperone protein Activated Repressed 52, 53
flhAB Export gate protein Activated Repressed 52, 53
pel Pel exopolysaccharide Repressed Activated 36, 37, 40, 42, 57
psl Psl exopolysaccharide Repressed Activated 36, 37
cdrAB Fibrillar adhesin protein Repressed Activated 36

The regulation of these flagellar biogenesis genes is intertwined in a complex regulatory cascade. It is now apparent that the cascade is headed by FleQ, an NtrC/NifA-type activator (53) (Fig. 1). Transcriptional activators belonging to the NtrC superfamily have been reported to work in concert with RpoN, the alternate sigma factor, sigma 54 (σ54), to activate a variety of genes that are regulated in response to external cues. Some of the genes regulated by σ54 are involved in RNA modification (58), the transition of Chlamydia from reticulate bodies to infectious bodies (59), response to heat shock in Escherichia coli (60), nitrogen utilization in E. coli (61), and the expression of alternate sigma factor σS (rpoS) (61).

As a NtrC/NifA-type activator, FleQ is no exception and works in concert with σ54 to regulate the expression of fleSR, which encodes the two-component regulatory system FleSR (class II) (53) (Fig. 1). This is supported by promoter fusion experiments showing that fleSR expression is regulated by σ54 and FleQ. It is of interest to note that while fleSR requires σ54 and FleQ for activation, the expression of fleQ is independent of σ54 and FleR; hence, fleQ is classified as a class I gene. Other class II genes include fleN, fliD encoding the flagella cap proteins, fliHIJ, fliL, genes encoded by the fliLMNOPQR operon (genes involved in flagella export), flgMN, fliS, fliT, flhG, and fleP. Additional Class II genes include flhAF (encoding flagellar biosynthesis proteins) and fliEFG-PA1103-fliIJ (encoding the structural parts of the flagellar basal body and flagellum-specific ATP synthase FliI) (56) (Fig. 1; Table 1).

Genes in class III are required for the assembly of the HBB (Fig. 1A) and are positively regulated by the class II response regulator FleR in a σ54-dependent manner (Fig. 1B). These genes include flgB and flgC encoding the flagellar basal-body rod proteins FlgB and FlgC, flgD the flagellar basal-body rod modification protein FlgD, and flgE encoding the flagella hook protein, flgF encoding the proximal rod protein, flgG encoding the distal rod protein, flgH encoding the L-ring protein, flgl encoding the P-ring protein, flgJ encoding the distal rod cap protein, flgKL encoding the hook-filament junction proteins, and fliK encoding the hook length control protein (47, 5154) (Table 1). Assembly of the HBB enables the export of the anti-sigma factor FlgM (52).

Class IV genes have in common that they require the sigma factor FliA (RpoF or σ28) instead of σ54 for expression. The expression of fliA appears to be constitutive, independent of FleQ, σ54, or any known flagella genes but is, however, left as unclassified as seen in a previous review (52, 53). However, during flagella biosynthesis, FliA is sequestered by its anti-sigma factor FlgM, until the flagella hook (HBB) is fully assembled. As indicated above, completion of the HBB induces the export of FlgM (52, 53) (Fig. 1), thus freeing FliA. Class IV genes regulated by FliA include fliC, fleL, cheAB, motAB, cheW, cheVR, flgMN, cheYZ, and fliC encoding the flagella filament protein (Fig. 1; Table 1). In P. aeruginosa, the sequestration of FliA by FlgM is antagonized by the HptB-HsbR-HsbA system by a mechanism described by Bhuwan et al. (62). Specifically, HsbR and HptB regulate the anti-sigma factor antagonist, HptA (in response to an unknown cue), to prevent the sequestration of FliA by FlgM through a partner switching mechanism (62).

REGULATION OF FleQ AND ITS ACTIVITY

FleQ directly regulates flhA, fliE, fliL, and fleSR (Fig. 1). However, the promoter regions of these genes can be distinguished based on the location of FleQ-binding sites. In fact, analysis of the transcription start site (TSS) by primer extension revealed two distinct FleQ-binding sites. For the fleSR promoter, the FleQ-binding site was located 67 bp upstream of the TSS of fleSR (56), with the upstream position being typical for NtrC-like regulators (6365). For flhA, fliE, and fliL, FleQ was determined to bind to the leader sequence of the flhA, fliE, and fliL promoters, in close proximity to the σ54 RNA polymerase (RNAP)-binding sites (56). The difference in the location of FleQ binding relative to the TSS and the σ54 RNAP-binding sites furthermore suggests two modes of σ54-dependent activation by FleQ, and thus, two modes of flagellar regulation in P. aeruginosa. The first mode refers to the typical model of transcription initiation from a distance for NtrC-like regulators (56, 66) via looping in the fleSR promoter and involves upstream binding of FleQ and interaction with bound RNAP via looping (Fig. 2A). In the second mode, FleQ binding occurs downstream of class II promoters adjacent to the RNAP-binding site. In this mode, FleQ likely contacts RNAP directly to activate transcription, without looping (Fig. 2B). This mode of FleQ binding is uncommon in NtrC-like regulators.

Fig 2.

Fig 2

FleQ regulates class II flagella-associated genes through distinct mechanisms. (A) FleQ binds upstream of the TSS of fleSR resulting in DNA looping and a subsequent initiation of transcription. (B) FleQ binds the leader sequence of flhA, fliE, and fliL and initiates transcription in a manner that does not result in DNA looping. Sizes of DNA sites or proteins are not drawn to scale.

Despite the differences in binding to class II promoters, FleQ binding and FleQ-dependent regulation of flagella-associated genes require the ATPase activity of FleQ (39, 55). The ATPase activity is thought to facilitate the production of energy (through ATP hydrolysis) required for the remodeling of the σ54 RNAP complex, from a closed σ54 RNAP/DNA complex to an open σ54 RNAP/DNA complex, with the remodeling switching the complex from inactive to active for transcription of downstream genes (67). Specifically, the central AAA+ ATPase domain of FleQ is necessary for ATP hydrolysis (6668).

Although FleQ (in)directly regulates and activates more than 40 genes involved in flagellar biogenesis (53), an important element in the regulation of flagellar gene expression is FleN. FleN is an anti-sigma factor (54) that post-transcriptionally modulates the activity of FleQ by binding directly to the ATPase AAA+ binding site, thus blocking the ATPase activity of FleQ and, in turn, reducing or impairing FleQ-dependent initiation of transcription (54, 55, 69) (Fig. 3). This is apparent considering that P. aeruginosa fleN deletion mutants display a multiflagellate phenotype (54, 69). The findings suggested FleN ensured the monoflagellated P. aeruginosa. Thus, FleN functions like a brake of FleQ to ensure the correct number of flagella per bacterium. This brake is reversible, as FleQ activates the expression of fleN (Fig. 1), suggesting a feedback mechanism to modulate the activity of both proteins to ensure the maintenance of the monoflagellated state under planktonic growth conditions (51, 55, 70).

Fig 3.

Fig 3

Transcriptional and post-transcriptional regulation of FleQ. (A) Transcription of fleQ is negatively regulated by AmrZ and Vfr. (B) The ATPase activity of FleQ is negatively affected by c-di-GMP and FleN. Post-transcriptional regulation of FleQ by FleN functions to maintain a monoflagellate P. aeruginosa. Rec, receiver domain; ATPase, ATPase domain; HTH, helix-turn-helix DNA-binding domain.

TRANSITION TO THE SESSILE MODE OF GROWTH COINCIDES WITH A SWITCH IN SIGMA FACTORS

While several studies have highlighted the role of flagella in attachment and the initial stages of biofilm formation (71, 72), later biofilm developmental stages coincide with the loss of flagellar-driven motility (35, 73) and the production of biofilm matrix components, such as exopolysaccharides (Pel, Psl, and alginate) and adhesins (CdrA) (19, 42, 43, 7478).

FleQ contributes to the transition from the planktonic to the sessile mode of growth in two ways: by repressing flagellar biogenesis genes and by activating the expression of genes contributing to the biofilm matrix, including genes involved in the biosynthesis of exopolysaccharides (Pel, Psl, and alginate) and adhesins (CdrAB) (3638, 40). Unlike the expression of flagellar genes, however, FleQ-dependent expression of genes related to the biofilm matrix (pel and psl or cdrA) is independent of σ54, ATPase activity of FleQ, and the FleQ σ54-binding domain (3638, 40, 79) (Fig. 4). Moreover, Baraquet and Harwood (36) reported that the cdrA promoter lacks the typical σ54 RNAP-binding site.

Fig 4.

Fig 4

Inverse regulation of flagella- and biofilm matrix-associated genes by FleQ. Under planktonic growth conditions and/or at low c-di-GMP levels, FleN-bound FleQ binds σ54-dependent promoters (flagella-associated genes) and activates expression in a σ54 and ATP-dependent manner. At the same time, expression of biofilm matrix-associated genes (e.g., pel) is repressed. FleQ binds to at least two boxes in the promoter region of biofilm matrix-associated genes. FleN (bound to FleQ) dimerizes in the presence of ATP, inducing a bend or kink in the intervening DNA. FleQ-dependent repression of extracellular polysaccharide (EPS) genes does not require ATPase activity and σ54. Under biofilm growth conditions and/or at high c-di-GMP levels, FleQ binds c-di-GMP which impairs its ATPase activity and association with σ54, resulting in FleQ ceasing to activate σ54-dependent promoters (e.g., of flagella-associated genes). C-di-GMP binding by FleQ relieves DNA bending, resulting in de-repression of biofilm matrix-associated genes (e.g., pel). The oligomerization state of FleQ is not addressed.

The findings suggest a transition to the biofilm mode of growth to coincide with FleQ regulating promoters that rely on sigma factors other than σ54. Interestingly, Baraquet and Harwood (36) identified putative −10 (CATATT) and −35 (TTAAAA) boxes, indicative of control by σ70 RNAP in the promoter region of cdrAB (Fig. 4). It is of note that P. aeruginosa PAO1 encodes 24 putative RNAP sigma factors, 19 of which are classified as σ70-like extra-cytoplasmic function sigma factors (80). It is possible that one of these σ70-like sigma factors participates in FleQ-mediated regulation of biofilm-related genes. While promoters of other FleQ-regulated biofilm genes have not been explored in such detail, the findings suggest that the two opposing behaviors, motility and biofilm, coincide with FleQ switching from regulating the expression of flagella-associated genes and dependence on σ54 to the expression of biofilm-related genes that are dependent on σ70-like sigma factors (or at least sigma factors other than σ54), suggesting a sigma factor-specific mechanism of regulation by FleQ. It is important to point out, however, that the change of FleQ, transitioning from a repressor to an activator (or vice versa), occurs in response to c-di-GMP and in the presence of FleN. The pivotal role of c-di-GMP levels in modulating FleQ activity is discussed in further detail below.

c-di-GMP-DEPENDENT REGULATION OF GENE EXPRESSION BY FleQ

The two different types of lifestyles have been associated with differing cellular levels of the secondary messenger c-di-GMP, with high c-di-GMP levels favoring the biofilm mode of growth, while low levels favor the motile, planktonic mode of growth (81). FleQ has been characterized as a c-di-GMP-responsive transcription factor that inversely regulates flagellar-driven motility and matrix production in response to the cellular levels of the secondary messenger c-di-GMP (3640, 79, 82). Specifically, at low c-di-GMP, FleQ positively regulates flagellar genes (39, 40, 51, 56) while repressing genes encoding the biofilm matrix components (3638). FleQ repressing pel expression is supported by a 2.8–20-fold increase in pel transcript abundance in a fleQ mutant relative to the wild-type strain (3638). At high c-di-GMP, FleQ ceases to activate flagellar genes but upregulates genes encoding biofilm matrix components including pel and psl and the adhesin cdrA (3640, 79, 82). The findings indicate that in addition to a switch in sigma factors, FleQ is furthermore subject to an additional level of control by c-di-GMP (Fig. 4). C-di-GMP enables FleQ to regulate genes resulting in opposing behaviors—motility and adhesiveness—enabling a switch in the modes of growth. FleQ binds to the promoters of genes encoding matrix-associated components regardless of c-di-GMP levels. However, FleQ binds to at least two sites on the promoters of the pel, psl, and cdrA promoters (36), with the binding to the promoter varying depending on the presence of FleN, ATP (hydrolysis), and c-di-GMP. In fact, FleQ, acting as a repressor or activator of genes encoding biofilm matrix components, is linked to the c-di-GMP level (37). These sites, referred to as boxes 1 and 2, have been identified in the pel promoter as CGCCTAAAAATTGACAGTT and TCATTAGATTGACGTTAAT located −62 and −5 bp, respectively, relative to the TSS (36). At one site (box 2), FleQ functions to repress pel gene expression, and at the other site (box 1), FleQ functions to activate pel expression in response to c-di-GMP (37). The importance of the FleQ boxes is reversed in the psl operon, where the box upstream of the TSS is required for activation and the FleQ box that overlaps the TSS is required for repression (36). Similar to the pel promoter, FleQ binds to the cdrA promoter. However, the cdrA promoter is characterized by three FleQ-binding sites, with one site located upstream of the TSS (ATTGTCGGTTTTTTGACGGTATT) and two sites located side-by-side downstream of the TSS (GTCATTTAACTGACGAATGCA and TGCTGGAAAACTGACGTGCGC). The upstream box is required for FleQ-mediated cdrAB repression in the absence of c-di-GMP, whereas the downstream boxes are required for FleQ-mediated cdrAB activation in the presence of c-di-GMP (36). The mechanism by which FleQ inversely regulates the expression of psl genes is not known (36).

The c-di-GMP-dependent switch of FleQ from a repressor to the activator and, thus, de-repression of biofilm-related genes, particularly pel, has been elucidated by Baraquet et al. (37, 40). At low c-di-GMP levels, FleQ binds to its two FleQ-binding sites on the pel promoter simultaneously. FleQ binding to both boxes promotes the DNA backbone between the first and second both to bend or kink, with the distortion preventing RNAP to bind to pel promoter, either by impairing the binding of the RNAP or by preventing RNAP bound to the pel promoter from forming an open complex, leading to pel repression (37) (Fig. 4). The DNA bending was found to be stimulated by FleN, occurs only when ATP is present, and disappears in the presence of c-di-GMP (37). In the presence of ATP, FleN (bound to FleQ) has been proposed to form dimers inducing a bending of the pel promoter by bridging the bound FleQ proteins. While direct evidence is lacking, it is possible that a similar distortion affects the transcription of genes encoding matrix-associated components other than pel, as inactivation of fleQ has likewise been shown to coincide with increased transcript abundance of psl, relative to the wild-type strain (3638).

In the presence of high c-di-GMP, FleQ undergoes a conformational change that probably induces a cascade of conformational changes in the FleQ/FleN/DNA complex such that the bending is relaxed (37, 40). The relief of the bending has been proposed to either induce RNAP binding or remodel RNAP binding. Moreover, FleQ is switched to an activator, with FleQ bound to pel box 1 favoring transcription initiation and binding of FleQ to pel box 2 favoring repression. Thus, c-di-GMP binding to FleQ relieves DNA distortion and activates gene expression without affecting the apparent protein occupancy on the DNA. The findings suggest that the conformation of the DNA intervening the two FleQ-binding sites (Box 1 and 2) plays a crucial role in the FleQ-dependent regulation of biofilm matrix-related genes, with bound FleQ acting as an activator or repressor depending on the DNA bending and the level of c-di-GMP (37). It is of interest to note that, unlike other regulators, FleQ switches from a repressor to an activator of biofilm genes without engaging/disengaging from the respective promoters but instead, by taking advantage of separate binding sites for each function, repression and activation.

While FleQ needs to bind to only one of its two binding sites (e.g., FleQ box 2 of pel promoter) for repression, evidence suggests that FleQ requires FleN for full activation of pel expression in response to c-di-GMP. FleQ forms a complex in the presence as well as in the absence of c-di-GMP with its antagonist FleN (37), with FleN continuing to exert its influence on FleQ concerning the expression of biofilm matrix-associated genes. This is apparent by the inactivation of fleN coinciding with decreased transcript abundance of pel and psl transcript abundance (38), while the inactivation of fleQ has the opposite effect, resulting in increased transcript abundance of pel and psl relative to the wild-type strain. The findings indicate that while flagellar gene expression by FleQ is regulated by FleN (FleN modulates FleQ activity), the activation of biofilm matrix-associated genes (pel, psl, and cdrAB) by FleQ is dependent on FleN (38, 83). It is of interest to note that while FleN remains complexed to FleQ regardless of the c-di-GMP levels, c-di-GMP induces conformational changes. For one, trypsin digestion profiles of FleQ and FleN differed in the presence and in the absence of c-di-GMP (37), suggesting c-di-GMP to induce a conformational change of a FleQ/FleN complex. Likewise, FleQ has been shown to undergo a conformational change when it binds c-di-GMP (37, 40). In contrast, FleQ does not undergo an obvious conformational change upon ATP binding, and ATP does not affect the conformational change of FleQ due to c-di-GMP binding (37, 40). FleQ and FleN interact irrespective of the presence of ATP hydrolysis (37). Moreover, while the ATPase activity of FleQ was required for flagellar gene expression, repression or activation of biofilm matrix-associated genes does not require ATP hydrolysis. Thus, FleQ functions as a repressor of pel and psl genes at low c-di-GMP levels in a manner dependent of FleN but independent of ATP hydrolysis, which further supports the σ54-independent mechanism of FleQ in the regulation of genes encoding exopolysaccharides and adhesins. In turn, at high c-di-GMP levels, activation of FleQ coincides with a conformational change.

c-di-GMP-BINDING SITES AND OLIGOMERIZATION STATE

FleQ harbors three domains, an N-terminal REC receiver domain, a central AAA+ ATPase central domain that contains a σ54 binding site, and a C-terminal helix-turn-helix DNA-binding domain (40, 51). The crystal structure of FleQ revealed three distinct motifs that are important for the binding of dimeric c-di-GMP to FleQ. These motifs include (i) amino acid residues LFRS at position 142–145 located at the N terminus of the AAA+ ATPase central domain, (ii) residues R185N186 located within the AAA+ ATPase central domain, past the Walker A motif, and (iii) the ExxxR334 motif located C-terminally of the helix-turn-helix DNA-binding domain of FleQ (40).

Upon c-di-GMP binding, the ATPase activity of FleQ is reduced, suggesting c-di-GMP to bind to the ATPase central domain to affect the ATPase activity of FleQ (38, 39). As a consequence, the expression of FleQ- and σ54-dependent flagellar genes is reduced upon c-di-GMP binding (38, 39) (Fig. 4). Moreover, c-di-GMP binding has been reported to coincide with the relief in the DNA distortion (37).

Additionally, c-di-GMP binding by FleQ has been linked to a change in the oligomerization state of FleQ. The transcriptional regulator FleQ belongs to the AAA+ family of bacterial enhancer-binding proteins (bEBPs). Members of this family undergo conformational changes in dimeric bEBPs forming a ring-shaped hexamer capable of binding upstream of the TSS of target genes upon phosphorylation (at the Rec domain). The conformational change results in the recruitment of the σ54-RNAP–promoter complex and the initiation of transcription in an ATPase-dependent manner (67, 84, 85). Despite a similar domain architecture, FleQ lacks both cognate sensor kinase and conserved REC domain residues that are crucial for phospho-transfer and phosphorylation-dependent conformational changes. Specifically, FleQ lacks the highly conserved phospho-acceptor residues (aspartate) present in NtrC subfamily of proteins and instead has a serine residue, and while it is possible that phosphorylation occurs at the serine residue, evidence is lacking to that effect (51). Despite the lack of apparent phospho-acceptor sites, FleQ has been reported to form dimers, trimers, tetramers, and hexamers in the presence or absence of ATP (40) and, unlike other bEBPs, spontaneously hexamerizes in solution, suggesting that FleQ appears to use a drastically different mechanism of regulation (40). While it is not known whether the dimeric form or a higher order oligomer (trimer, tetramer, or hexamer) is the stable form of FleQ to regulate flagella-associated genes, recent evidence suggests that at low c-di-GMP levels, hexameric FleQ is the functional pel transcriptional repressor and the target for c-di-GMP (40). As revealed by the crystal structure of c-di-GMP-complexed FleQ, c-di-GMP interacts with the AAA+ ATPase domain (40). The interactions lead to active site obstruction at the ATP-binding pocket, resulting in allosteric inhibition of the ATPase activity and inhibition of ATP-dependent activation of flagella genes (40). The interaction has furthermore been shown to result in the destabilization of the hexameric state of FleQ (40). The change in the oligomerization state likely results in the relief of DNA distortion at the promoter site and subsequent activation of genes encoding matrix exopolysaccharides and adhesins. At the same time, inhibition of the ATPase activity upon c-di-GMP binding results in the cessation of flagellar gene expression by FleQ.

c-di-GMP provides an additional level of control on the production of matrix polysaccharides. However, the regulation appears to be strain specific. For example, the main exopolysaccharide Psl by P. aeruginosa strain PAO1 is only regulated at the transcriptional level by c-di-GMP (42, 86). In contrast, the synthesis of Pel, the primary matrix polysaccharide in P. aeruginosa strain PA14, is regulated by c-di-GMP at the transcriptional and post-transcriptional levels (38, 57). Post-transcriptional regulation occurs by c-di-GMP binding to the PelD protein, with c-di-GMP binding activating the production of Pel polysaccharide (57, 87). The biosynthesis of the alginate polysaccharide has likewise been linked to c-di-GMP, with increased c-di-GMP levels positively affecting the expression of alginate biosynthesis genes (88). In addition to alginate biosynthesis being regulated by c-di-GMP at the transcriptional level, evidence suggests that c-di-GMP also affects alginate at the post-transcriptional level (89).

AmrZ PROVIDES AN ADDITIONAL LEVEL OF FleQ CONTROL TO FINE-TUNE MATRIX COMPOSITION AND MOTILITY

Early studies demonstrated that the fleQ promoter is not autoregulated by FleQ (51, 82). However, at the transcriptional level, fleQ expression is likely positively regulated by σ70-like sigma factors (82) and negatively regulated by the global regulator of virulence factor expression, Vfr (82), and the quorum sensing regulatory protein LasR (82) (Fig. 3). An additional level of control of fleQ expression is conferred by the Alginate and Motility Regulator Z, AmrZ (Fig. 3). AmrZ (previously known as AlgZ) is a global transcriptional regulator of genes involved in exopolysaccharide production (Pel, Psl, and alginate), motility (flagella and twitching motility), and c-di-GMP metabolism (35, 41, 9096). Similar to FleQ, AmrZ acts as both, an activator and a repressor, and inversely regulates genes involved in alginate exopolysaccharide production and motility (flagella and pili-associated genes) (92, 95, 96). AmrZ has been reported to repress the psl operon-encoding genes required for Psl exopolysaccharide production by binding the psl promoter and repressing its transcription (96, 97). Jones et al. showed AmrZ to increase the expression of pelB by 6.64 in an RNA-seq experiment, while chromatin immunoprecipitation (ChIP-seq) confirmed AmrZ binding to the pelB promoter (95). However, a later study showed an enhanced level of Pel polysaccharide in ΔamrZ with transcript levels of pelA and pelG not being different in the ΔamrZ vs the wild type, suggesting that AmrZ might be inhibiting the production of Pel through a mechanism that is non-transcriptional (98).

RNA-seq studies demonstrated AmrZ to contribute to the expression of fleQ (95), with RNA-seq, ChiP-seq, and electrophoretic mobility shift assays confirming AmrZ to be a direct repressor of fleQ expression (95). Biochemical characterization of ArmZ furthermore demonstrated that two amino acid residues (Lys18 and Arg22), located in the β-sheet of AmrZ DNA-binding domain, are important for DNA-binding to the fleQ promoter as well as the repressive function by AmrZ on fleQ expression (35, 41, 91).

Similar to FleQ, AmrZ functions in concert with two sigma factors. However, while FleQ works in concert with σ54 to regulate flagellar-gene expression and σ70 (or sigma70-like sigma factors) to regulate biofilm-associated genes, AmrZ works in concert with the AlgT sigma factor σ22 (35, 73). Additionally, σ70-binding sites were found close to the amrZ-binding site on psl (96), suggesting AmrZ also works in concert with σ70 to regulate psl transcription. In non-mucoid P. aeruginosa strains, AlgT (also known as AlgU) activity is modulated by the anti-sigma factor, MucA, with full sequestration of AlgT by MucA inhibiting AmrZ activity and resulting in the overall repression of alginate production and de-repression of fleQ (Fig. 5). It is of interest to note that the psl promoter activity was found to be reduced by 30% in a mucA mutant overexpressing alginate, suggesting an inverse correlation in the expression of psl and alginate polysaccharide by AmrZ (37, 96, 97). In contrast, deregulation resulting in free AlgT, as in response to environmental conditions or mutation of mucA, leads to the activation of amrZ and subsequent expression of alginate genes (Fig. 5).

Fig 5.

Fig 5

Regulation of amrZ gene expression and fine-tuning of the exopolysaccharide composition by P. aeruginosa biofilms (high c-di-GMP levels). Expression of amrZ is dependent on the availability of the AlgT sigma factor. When AlgT (also known as AlgU) is sequestered by the anti-sigma factor, MucA, amrZ gene expression is repressed. However, under stressful conditions (e.g., biofilm and CF lung environment), AlgT is released from MucA and becomes available to enable amrZ gene expression. AmrZ directly represses psl but enhances alg and cdrAB expression directly and gcbA gene expression indirectly. AmrZ may or may not activate the expression of pel under conditions of high c-di-GMP. In contrast, FleQ activates the expression of psl, pel, and cdrAB at high levels of c-di-GMP. The expression of fleQ and post-transcriptional activation via c-di-GMP of FleQ is AmrZ dependent. The availability of AmrZ and FleQ and their distinct effects on Pel, Psl, and alginate production enables fine-tuning the composition of the exopolysaccharides present in the biofilm matrix. Arrows indicate activation while blunt-ended lines indicate repression of gene expression. Solid lines indicate direct regulation, while dashed lines indicate indirect regulation. Red lines indicate unknown regulations.

AmrZ also regulates FleQ at the post-translational level by modulating the intracellular levels of c-di-GMP. Relative to the wild type, strains inactivated in amrZ are characterized by significantly higher levels of c-di-GMP (98). RNA-seq and qRT-PCR indicated AmrZ to regulate the expression of gcbA encoding the diguanylate cyclase GcbA (PA4843, also known as AdcA) (98). gcbA was not only found to be among the most highly expressed genes by ΔamrZ, but the diguanylate cyclase GcbA was also determined to be the main cause for the elevated c-di-GMP levels present in ΔamrZ (98). Elevated c-di-GMP has several consequences. For one, an increase in c-di-GMP contributes to FleQ switching from activating flagellar-associated genes to de-repressing biofilm-associated genes. Second, GcbA-generated c-di-GMP is sensed by two effector relay proteins, FlgZ and PA4324 (95, 98). While the mechanism for PA4324 is not known, FlgZ interacts with the flagellar stator MotC upon c-di-GMP binding, impairing flagella rotation. Lastly, both FlgZ and PA4324 mediate the repression of swarming motility (98), indicating AmrZ and GcbA to regulate swarming motility through a c-di-GMP-dependent mechanism (98).

Overall, both AmrZ and FleQ contribute to the expression of genes encoding exopolysaccharides but somewhat in an opposing manner under determined environmental circumstances. For example, at high c-di-GMP levels, AmrZ activates alginate production and represses psl but may or may not activate pel expression. FleQ activates both psl and pel expression without affecting alginate gene expression at high c-di-GMP levels. Considering the effect of the two proteins on exopolysaccharides, AmrZ regulating fleQ provides fine-tuning to FleQ activity at high c-di-GMP levels, with the fine-tuning affecting the overall composition of the biofilm matrix (Fig. 5). This is apparent by the matrix of mucoid strains primarily being composed of alginate (99) polysaccharide, whereas in non-mucoid strains, Pel and/or Psl polysaccharides appear to be the predominant polysaccharide (100102) (Fig. 5).

CONCLUSION

The FleQ-mediated transition of P. aeruginosa from a free-living, planktonic mode of growth to a sessile, communal mode of growth coincides with FleQ undergoing many changes at the transcriptional and post-transcriptional level. Under planktonic, low c-di-GMP conditions, FleQ (post-transcriptionally regulated by FleN) works in concert with σ54 to regulate flagella synthesis and motility in P. aeruginosa, while repressing biofilm matrix-associated genes. Transition by P. aeruginosa to the sessile mode of growth coincides with FleQ-binding c-di-GMP and ceasing ATPase activity, changing oligomerization state, and switching sigma factors (σ54–σ70). As a result, FleQ ceases to activate flagella genes and switches from a repressor to an activator of biofilm matrix-associated genes.

FleQ function is affected by various factors in a hierarchical manner that also contribute to the transition in growth modes. For example, FleQ is regulated by Vfr and AmrZ at the transcriptional level, as well as c-di-GMP, FleN, and AmrZ at the post-transcriptional level with AmrZ contributing to the cellular levels of c-di-GMP, via the diguanylate cyclase GcbA (AdcA). Additionally, FleQ regulates the activity of RNAPs bearing two separate sigma factors, σ54 and σ70.

FleQ is not specific to P. aeruginosa alone (Fig. 6), with FleQ having been identified to play similar roles of flagella biosynthesis in other Pseudomonas species such as P. fluorescens (47), P. syringae (103), Pseudomonas stutzeri (104), and P. putida (47, 105, 106). Additionally, FleQ inversely regulates flagella and biofilm matrix genes in P. putida (107) and in P. syringae (104, 108). FleQ is also found to act as a transcriptional regulator of flagella biosynthesis in Legionella pneumophila (109). Moreover, homologs of FleQ (Fig. 6) have been identified in other Gram-negative bacteria like Helicobacter pylori (FlgR) (110), Caulobacter crescentus (FlbD) (111), Vibrio cholerae (FlrA) (112, 113), and Shewanella putrefaciens (FlrA) (114). The alignment of FleQ and FleQ homologs in other species shows the N- and C-terminal regions to be highly variable, with amino acid residues toward the center of these proteins being generally conserved (Fig. 6). These FleQ homologs play similar roles in motility and regulation of gene expression (51). However, their role in biofilm formation and regulation of biofilm matrix-associated genes remains unknown.

Fig 6.

Fig 6

Rooted phylogenetic tree of FleQ and its homologs. (A) Alignment of FleQ and FleQ homologs. The alignment was carried out using Clustal Omega (116). Cc, C. crescentus; Hp, H. pylori; Vc, V. cholerae; Sp, S. putrefaciens; Pa, P. aeruginosa; Lp, L. pneumophila. *, highly conserved amino acid residues; : and ., moderately conserved amino acid residues. (B) Phylogenetic tree derived from Clustal Omega-generated alignment (115).

Additional questions regarding FleQ remain open. For example, it is unclear if all genes regulated by FleQ at high c-di-GMP levels are σ70-dependent. Likewise, while FleQ has been reported to bind as a hexamer to the pel promoter at low c-di-GMP, the oligomerization state of FleQ when bound to flagella gene promoters at low c-di-GMP and promoters of biofilm matrix-associated genes at high and low levels of c-di-GMP is not well understood. Moreover, the role of AmrZ in fine-tuning FleQ is being challenged. While AmrZ acts upstream of FleQ and represses its transcription in P. aeruginosa, a recent study suggested FleQ to repress the expression of amrZ in P. putida and P. fluorescens (47), indicating a feedback loop. Whether FleQ likewise acts as a repressor of amrZ in P. aeruginosa is as of yet unknown and requires unraveling of the molecular mechanism of repression.

Contributor Information

Karin Sauer, Email: ksauer@binghamton.edu.

Michael Y. Galperin, NCBI, NLM, National Institutes of Health, Bethesda, Maryland, USA

REFERENCES

  • 1. Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, Sanchez M, Martinez JA. 1999. Severe community-acquired pneumonia risk factors and follow-up epidemiology. Am J Respir Crit Care Med 160:923–929. doi: 10.1164/ajrccm.160.3.9901107 [DOI] [PubMed] [Google Scholar]
  • 2. Sadikot RT, Blackwell TS, Christman JW, Prince AS. 2005. State of the art pathogen – host interactions in Pseudomonas aeruginosa pneumonia respiratory infections. Am J Respir Crit Care Med 171:1209–1223. doi: 10.1164/rccm.200408-1044SO [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762–764. doi: 10.1038/35037627 [DOI] [PubMed] [Google Scholar]
  • 4. Cole SJ, Records AR, Orr MW, Linden SB, Lee VT. 2014. Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect Immun 82:2048–2058. doi: 10.1128/IAI.01652-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Nickel JC, Downey J, Costerton JW. 1992. Movement of Pseudomonas aeruginosa along catheter surfaces. a mechanism in pathogenesis of catheter-associated infection. Urology 39:93–98. doi: 10.1016/0090-4295(92)90053-y [DOI] [PubMed] [Google Scholar]
  • 6. Bodey GP, Bolivar R, Fainstein V, Jadeja L. 1983. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 5:279–313. doi: 10.1093/clinids/5.2.279 [DOI] [PubMed] [Google Scholar]
  • 7. Morrison AJ, Wenzel RP. 1984. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 3:S627–42. doi: 10.1093/clinids/6.supplement_3.s627 [DOI] [PubMed] [Google Scholar]
  • 8. Gellatly SL, Hancock REW. 2013. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 67:159–173. doi: 10.1111/2049-632X.12033 [DOI] [PubMed] [Google Scholar]
  • 9. Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S, GLIMP . 2018. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J 52:1701190. doi: 10.1183/13993003.01190-2017 [DOI] [PubMed] [Google Scholar]
  • 10. CDC . 2019. Antibiotic resistance threats in the United States 2019. CDC’s annual antibiotic resistance threat report
  • 11. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399:629–655. doi: 10.1016/S0140-6736(21)02724-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A. 2020. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. The Lancet 396:1204–1222. doi: 10.1016/S0140-6736(20)30925-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Cross AS. 1985. Evolving epidemiology of Pseudomonas aeruginosa infections. Eur J Clin Microbiol 4:156–159. doi: 10.1007/BF02013589 [DOI] [PubMed] [Google Scholar]
  • 14. Percival SL, Hill KE, Malic S, Thomas DW, Williams DW. 2011. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen 19:1–9. doi: 10.1111/j.1524-475X.2010.00651.x [DOI] [PubMed] [Google Scholar]
  • 15. Gupta K, Marques CNH, Petrova OE, Sauer K. 2013. Antimicrobial tolerance of Pseudomonas aeruginosa biofilms is activated during an early developmental stage and requires the two- component hybrid SagS. J Bacteriol 195:4975–4987. doi: 10.1128/JB.00732-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Poudyal B, Sauer K. 2018. The ABC of biofilm drug tolerance: the MerR-like regulator contributing to the tolerance of Pseudomonas aeruginosa biofilms to tobramycin. Antimicrob Agents Chemother 62:1–19. doi: 10.1128/AAC.01981-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kim J, Hahn J-S, Franklin MJ, Stewart PS, Yoon J. 2009. Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents. J Antimicrob Chemother 63:129–135. doi: 10.1093/jac/dkn462 [DOI] [PubMed] [Google Scholar]
  • 18. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. 2008. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 68:223–240. doi: 10.1111/j.1365-2958.2008.06152.x [DOI] [PubMed] [Google Scholar]
  • 19. Sauer K, Stoodley P, Goeres DM, Hall-Stoodley L, Burmølle M, Stewart PS, Bjarnsholt T. 2022. The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat Rev Microbiol 20:608–620. doi: 10.1038/s41579-022-00767-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Thi MTT, Tam M, Wibowo D, Rehm BHA. 2020. Pseudomonas aeruginosa biofilms. IJMS 21:8671. doi: 10.3390/ijms21228671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Scoffone VC, Trespidi G, Chiarelli LR, Barbieri G, Buroni S. 2019. Quorum sensing as antivirulence target in cystic fibrosis pathogens. Int J Mol Sci 20:1838. doi: 10.3390/ijms20081838 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Alhede M, Bjarnsholt T, Givskov M, Alhede M. 2014. Pseudomonas aeruginosa biofilms. mechanisms of immune evasion. Adv Appl Microbiol 86:1–40. doi: 10.1016/B978-0-12-800262-9.00001-9 [DOI] [PubMed] [Google Scholar]
  • 23. Kirby AE, Garner K, Levin BR. 2012. The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilms. Antimicrob Agents Chemother 56:2967–2975. doi: 10.1128/AAC.06480-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A, Molin S, Pitts B, Stewart PS. 2004. Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 70:6188–6196. doi: 10.1128/AEM.70.10.6188-6196.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother 47:317–323. doi: 10.1128/AAC.47.1.317-323.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230:13–18. doi: 10.1016/S0378-1097(03)00856-5 [DOI] [PubMed] [Google Scholar]
  • 27. Roberts ME, Stewart PS. 2004. Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation. Antimicrob Agents Chemother 48:48–52. doi: 10.1128/AAC.48.1.48-52.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Drenkard E. 2003. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 5:1213–1219. doi: 10.1016/j.micinf.2003.08.009 [DOI] [PubMed] [Google Scholar]
  • 29. Suci PA, Mittelman MW, Yu FP, Geesey GG. 1994. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 38:2125–2133. doi: 10.1128/AAC.38.9.2125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. 2016. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14:563–575. doi: 10.1038/nrmicro.2016.94 [DOI] [PubMed] [Google Scholar]
  • 31. Flemming HC. 2016. Eps—then and now. Microorganisms 4:1–18. doi: 10.3390/microorganisms4040041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Petrova OE, Sauer K. 2009. A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development. PLoS Pathog 5:e1000668. doi: 10.1371/journal.ppat.1000668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Park S, Sauer K. 2021. SagS and its unorthodox contributions to Pseudomonas aeruginosa biofilm development. Biofilm 3:100059. doi: 10.1016/j.bioflm.2021.100059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Park S, Sauer K. 2022. Controlling biofilm development through cyclic di-GMP signaling. Adv Exp Med Biol 1386:69–94. doi: 10.1007/978-3-031-08491-1_3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Tart AH, Blanks MJ, Wozniak DJ. 2006. The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates. J Bacteriol 188:6483–6489. doi: 10.1128/JB.00636-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Baraquet C, Harwood CS. 2016. FleQ DNA binding consensus sequence revealed by studies of FleQ-dependent regulation of biofilm gene expression in Pseudomonas aeruginosa. J Bacteriol 198:178–186. doi: 10.1128/JB.00539-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Baraquet C, Murakami K, Parsek MR, Harwood CS. 2012. The FleQ protein from Pseudomonas aeruginosa functions as both a repressor and an activator to control gene expression from the Pel operon promoter in response to c-di-GMP. Nucleic Acids Res 40:7207–7218. doi: 10.1093/nar/gks384 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Hickman JW, Harwood CS. 2008. Identification of FleQ from Pseudomonas aeruginosa as a c-di-GMP-responsive transcription factor. Mol Microbiol 69:376–389. doi: 10.1111/j.1365-2958.2008.06281.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Baraquet C, Harwood CS. 2013. Cyclic diguanosine monophosphate represses bacterial flagella synthesis by interacting with the Walker A motif of the enhancer-binding protein FleQ. Proc Natl Acad Sci USA 110:18478–18483. doi: 10.1073/pnas.1318972110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Matsuyama BY, Krasteva PV, Baraquet C, Harwood CS, Sondermann H, Navarro MVAS. 2016. Mechanistic insights into c-di-GMP–dependent control of the biofilm regulator FleQ from Pseudomonas aeruginosa. Proc Natl Acad Sci USA 113:E209–18. doi: 10.1073/pnas.1523148113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Ramsey DM, Baynham PJ, Wozniak DJ. 2005. Binding of Pseudomonas aeruginosa AlgZ to sites upstream of the algZ promoter leads to repression of transcription. J Bacteriol 187:4430–4443. doi: 10.1128/JB.187.13.4430-4443.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Colvin KM, Irie Y, Tart CS, Urbano R, Whitney JC, Ryder C, Howell PL, Wozniak DJ, Parsek MR. 2012. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ Microbiol 14:1913–1928. doi: 10.1111/j.1462-2920.2011.02657.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. 2002. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184:1140–1154. doi: 10.1128/jb.184.4.1140-1154.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Mikkelsen H, Sivaneson M, Filloux A. 2011. Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. Environ Microbiol 13:1666–1681. doi: 10.1111/j.1462-2920.2011.02495.x [DOI] [PubMed] [Google Scholar]
  • 45. Karatan E, Watnick P. 2009. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev 73:310–347. doi: 10.1128/MMBR.00041-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Jiménez-Fernández A, López-Sánchez A, Jiménez-Díaz L, Navarrete B, Calero P, Platero AI, Govantes F. 2016. Complex interplay between FleQ, cyclic diguanylate and multiple σ factors coordinately regulates flagellar motility and biofilm development in Pseudomonas putida. PLoS One 11:e0163142. doi: 10.1371/journal.pone.0163142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Blanco-Romero E, Redondo-Nieto M, Martínez-Granero F, Garrido-Sanz D, Ramos-González MI, Martín M, Rivilla R. 2018. Genome-wide analysis of the FleQ direct regulon in Pseudomonas fluorescens F113 and Pseudomonas putida KT2440. Sci Rep 8:13145. doi: 10.1038/s41598-018-31371-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Casaz P, Happel A, Keithan J, Read DL, Strain SR, Levy SB. 2001. The Pseudomonas fluorescens transcription activator AdnA is required for adhesion and motility. Microbiology 147:355–361. doi: 10.1099/00221287-147-2-355 [DOI] [PubMed] [Google Scholar]
  • 49. Robleto EA, López-Hernández I, Silby MW, Levy SB. 2003. Genetic analysis of the AdnA regulon in Pseudomonas fluorescens: nonessential role of flagella in adhesion to sand and biofilm formation. J Bacteriol 185:453–460. doi: 10.1128/JB.185.2.453-460.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Nogales J, Vargas P, Farias GA, Olmedilla A, Sanjuán J, Gallegos MT. 2015. FleQ coordinates flagellum-dependent and-independent motilities in Pseudomonas syringae pv. tomato DC3000. Appl Environ Microbiol 81:7533–7545. doi: 10.1128/AEM.01798-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Arora SK, Ritchings BW, Almira EC, Lory S, Ramphal R. 1997. A transcriptional activator, FleQ, regulates mucin adhesion and flagellar gene expression in Pseudomonas aeruginosa in a cascade manner. J Bacteriol 179:5574–5581. doi: 10.1128/jb.179.17.5574-5581.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Bouteiller M, Dupont C, Bourigault Y, Latour X, Barbey C, Konto-Ghiorghi Y, Merieau A. 2021. Pseudomonas flagella: generalities and specificities. Int J Mol Sci 22:3337. doi: 10.3390/ijms22073337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Dasgupta N, Wolfgang MC, Goodman AL, Arora SK, Jyot J, Lory S, Ramphal R. 2003. A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 50:809–824. doi: 10.1046/j.1365-2958.2003.03740.x [DOI] [PubMed] [Google Scholar]
  • 54. Dasgupta N, Arora SK, Ramphal R. 2000. fleN, a gene that regulates flagellar number in Pseudomonas aeruginosa. J Bacteriol 182:357–364. doi: 10.1128/JB.182.2.357-364.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Banerjee P, Raghav S, Goswami HN, Jain D, Chanchal. 2021. The antiactivator FleN uses an allosteric mechanism to regulate Σ54-dependent expression of flagellar genes in Pseudomonas aeruginosa. Sci Adv 7:eabj1792. doi: 10.1126/sciadv.abj1792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Jyot J, Dasgupta N, Ramphal R. 2002. FleQ, the major flagellar gene regulator in Pseudomonas aeruginosa, binds to enhancer sites located either upstream or atypically downstream of the RpoN binding site. J Bacteriol 184:5251–5260. doi: 10.1128/JB.184.19.5251-5260.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Lee VT, Matewish JM, Kessler JL, Hyodo M, Hayakawa Y, Lory S. 2007. A cyclic-di-GMP receptor required for bacterial exopolysaccharide production. Mol Microbiol 65:1474–1484. doi: 10.1111/j.1365-2958.2007.05879.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Genschik P, Drabikowski K, Filipowicz W, Embo WJ. 1998. Characterization of the Escherichia coli RNA 3-terminal phosphate cyclase and its σ54-regulated operon. J Biol Chem 273:25516–25526. doi: 10.1074/jbc.273.39.25516 [DOI] [PubMed] [Google Scholar]
  • 59. Soules KR, LaBrie SD, May BH, Hefty PS. 2020. Sigma 54-regulated transcription is associated with membrane reorganization and type III secretion effectors during conversion to infectious forms of Chlamydia trachomatis. mBio 11:e01725-20. doi: 10.1128/mBio.01725-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Weiner L, Brissette JL, Model P. 1991. Stress-induced expression of the Escherichia coli phage shock protein operon is dependent on Σ54 and modulated by positive and negative feedback mechanisms. Genes Dev 5:1912–1923. doi: 10.1101/gad.5.10.1912 [DOI] [PubMed] [Google Scholar]
  • 61. Dong T, Yu R, Schellhorn H. 2011. Antagonistic regulation of motility and transcriptome expression by RpoN and RpoS in Escherichia coli. Mol Microbiol 79:375–386. doi: 10.1111/j.1365-2958.2010.07449.x [DOI] [PubMed] [Google Scholar]
  • 62. Bhuwan M, Lee HJ, Peng HL, Chang HY. 2012. Histidine-containing phosphotransfer protein-B (HptB) regulates swarming motility through partner-switching system in Pseudomonas aeruginosa PAOI1 strain. J Biol Chem 287:1903–1914. doi: 10.1074/jbc.M111.256586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Brown DR, Barton G, Pan Z, Buck M, Wigneshweraraj S. 2014. Nitrogen stress response and stringent response are coupled in Escherichia coli. Nat Commun 5:4115. doi: 10.1038/ncomms5115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Dusha I, Austin S, Dixon R. 1999. The upstream region of the NodD3 gene of Sinorhizobium meliloti carries enhancer sequences for the transcriptional activator NtrC. FEMS Microbiol Lett 179:491–499. doi: 10.1111/j.1574-6968.1999.tb08768.x [DOI] [PubMed] [Google Scholar]
  • 65. Foster-Hartnett D, Cullen PJ, Monika EM, Kranz RG. 1994. A new type of NtrC transcriptional activator. J Bacteriol 176:6175–6187. doi: 10.1128/jb.176.20.6175-6187.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Wyman C, Rombel I, North AK, Bustamante C, Kustu S. 1997. Unusual oligomerization required for activity of NtrC, a bacterial enhancer-binding protein. Science 275:1658–1661. doi: 10.1126/science.275.5306.1658 [DOI] [PubMed] [Google Scholar]
  • 67. Bush M, Dixon R. 2017. The role of bacterial enhancer binding proteins as specialized activators of Σ54-dependent transcription. Microbiol Mol Biol Rev 76:497–529. doi: 10.1128/MMBR.00006-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Bose D, Joly N, Pape T, Rappas M, Schumacher J, Buck M, Zhang X. 2008. Dissecting the ATP hydrolysis pathway of bacterial enhancer-binding proteins. Biochem Soc Trans 36:83–88. doi: 10.1042/BST0360083 [DOI] [PubMed] [Google Scholar]
  • 69. Dasgupta N, Ramphal R. 2001. Interaction of the antiactivator FleN with the transcriptional activator FleQ regulates flagellar number in Pseudomonas aeruginosa. J Bacteriol 183:6636–6644. doi: 10.1128/JB.183.22.6636-6644.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Banerjee P, Jain D, Chanchal . 2017. ATP-induced structural remodeling in the antiactivator FleN enables formation of the functional dimeric form. Structure 25:243–252. doi: 10.1016/j.str.2016.11.022 [DOI] [PubMed] [Google Scholar]
  • 71. O’Toole GA, Kolter R. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30:295–304. doi: 10.1046/j.1365-2958.1998.01062.x [DOI] [PubMed] [Google Scholar]
  • 72. Toutain CM, Caizza NC, Zegans ME, O’Toole GA. 2007. Roles for flagellar stators in biofilm formation by Pseudomonas aeruginosa. Res Microbiol 158:471–477. doi: 10.1016/j.resmic.2007.04.001 [DOI] [PubMed] [Google Scholar]
  • 73. Garrett ES, Perlegas D, Wozniak DJ. 1999. Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor algT (algU). J Bacteriol 181:7401–7404. doi: 10.1128/JB.181.23.7401-7404.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Stoodley P, Sauer K, Davies DG, Costerton JW. 2002. Biofilms as complex differentiated communities. Annu Rev Microbiol 56:187–209. doi: 10.1146/annurev.micro.56.012302.160705 [DOI] [PubMed] [Google Scholar]
  • 75. Martin DW, Schurr MJ, Mudd MH, Govan JRW, Holloway BW, Deretic V. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci USA 90:8377–8381. doi: 10.1073/pnas.90.18.8377 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Xu A, Zhang M, Du W, Wang D, Ma LZ. 2021. A molecular mechanism for how sigma factor AlgT and transcriptional regulator AmrZ inhibit twitching motility in Pseudomonas aeruginosa. Environ Microbiol 23:572–587. doi: 10.1111/1462-2920.14985 [DOI] [PubMed] [Google Scholar]
  • 77. Hassett MR, Parsek AK, Jeffers JG, Leid CJ, Willson ME, Shirtliff DJ. 2005. The exopolysaccharide alginate protects. J. Immunol 175:7512–7518. doi: 10.4049/jimmunol.175.11.7512 [DOI] [PubMed] [Google Scholar]
  • 78. Rybtke M, Berthelsen J, Yang L, Høiby N, Givskov M, Tolker-Nielsen T. 2015. The LapG protein plays a role in Pseudomonas aeruginosa biofilm formation by controlling the presence of the CdrA adhesin on the cell surface. Microbiologyopen 4:917–930. doi: 10.1002/mbo3.301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Borlee BR, Goldman AD, Murakami K, Samudrala R, Wozniak DJ, Parsek MR. 2010. Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol Microbiol 75:827–842. doi: 10.1111/j.1365-2958.2009.06991.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Potvin E, Sanschagrin F, Levesque RC. 2008. Sigma factors in Pseudomonas aeruginosa. FEMS Microbiol Rev 32:38–55. doi: 10.1111/j.1574-6976.2007.00092.x [DOI] [PubMed] [Google Scholar]
  • 81. Römling U, Galperin MY, Gomelsky M. 2013. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 77:1–52. doi: 10.1128/MMBR.00043-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Dasgupta N, Ferrell EP, Kanack KJ, West SEH, Ramphal R. 2002. fleQ, the gene encoding the major flagellar regulator of Pseudomonas aeruginosa, is Σ70 dependent and is downregulated by Vfr, a Homolog of Escherichia coli cyclic AMP receptor protein. J Bacteriol 184:5240–5250. doi: 10.1128/JB.184.19.5240-5250.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Torres-Sánchez L, Sana TG, Decossas M, Hashem Y, Krasteva PV. 2023. Structures of the P. aeruginosa FleQ-FleN master regulators reveal large-scale conformational switching in motility and biofilm control. Proc Natl Acad Sci USA 120:e2312276120. doi: 10.1073/pnas.2312276120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. De Carlo S, Chen B, Hoover TR, Kondrashkina E, Nogales E, Nixon BT. 2006. The structural basis for regulated assembly and function of the transcriptional activator NtrC. Genes Dev 20:1485–1495. doi: 10.1101/gad.1418306 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Lee S-Y, De La Torre A, Yan D, Kustu S, Nixon BT, Wemmer DE. 2003. Regulation of the transcriptional activator NtrC1: structural studies of the regulatory and AAA + ATPase domains. Genes Dev 17:2552–2563. doi: 10.1101/gad.1125603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Hickman JW, Tifrea DF, Harwood CS. 2005. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc Natl Acad Sci USA 102:14422–14427. doi: 10.1073/pnas.0507170102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Whitney JC, Colvin KM, Marmont LS, Robinson H, Parsek MR, Howell PL. 2012. Structure of the cytoplasmic region of PelD, a degenerate diguanylate cyclase receptor that regulates exopolysaccharide production in Pseudomonas aeruginosa. J Biol Chem 287:23582–23593. doi: 10.1074/jbc.M112.375378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Liang Z, Rybtke M, Kragh KN, Johnson O, Schicketanz M, Zhang YE, Andersen JB, Tolker-Nielsen T. 2022. Transcription of the alginate operon in Pseudomonas aeruginosa is regulated by c-di-GMP. Microbiol Spectr 10:e0067522. doi: 10.1128/spectrum.00675-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Whitney JC, Whitfield GB, Marmont LS, Yip P, Neculai AM, Lobsanov YD, Robinson H, Ohman DE, Howell PL. 2015. Dimeric c-di-GMP is required for post-translational regulation of alginate production in Pseudomonas aeruginosa. J Biol Chem 290:12451–12462. doi: 10.1074/jbc.M115.645051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Tart AH, Wolfgang MC, Wozniak DJ. 2005. The alternative sigma factor AlgT represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fleQ. J Bacteriol 187:7955–7962. doi: 10.1128/JB.187.23.7955-7962.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Baynham PJ, Ramsey DM, Gvozdyev BV, Cordonnier EM, Wozniak DJ. 2006. The Pseudomonas aeruginosa ribbon-helix-helix DNA-binding protein AlgZ (AmrZ) controls twitching motility and biogenesis of type IV pili. J Bacteriol 188:132–140. doi: 10.1128/JB.188.1.132-140.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Baynham PJ, Wozniak DJ. 1996. Identification and characterization of AlgZ, an AlgT-dependent DNA-binding protein required for Pseudomonas aeruginosa algD transcription. Mol Microbiol 22:97–108. doi: 10.1111/j.1365-2958.1996.tb02659.x [DOI] [PubMed] [Google Scholar]
  • 93. Pryor EE, Waligora EA, Xu B, Dellos-Nolan S, Wozniak DJ, Hollis T. 2012. The transcription factor AmrZ utilizes multiple DNA binding modes to recognize activator and repressor sequences of Pseudomonas aeruginosa virulence. PLoS Pathog 8:e1002648. doi: 10.1371/journal.ppat.1002648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Martínez-Granero F, Redondo-Nieto M, Vesga P, Martín M, Rivilla R. 2014. AmrZ is a global transcriptional regulator implicated in iron uptake and environmental adaption in P. fluorescens F113. BMC Genomics 15:237. doi: 10.1186/1471-2164-15-237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Jones CJ, Newsom D, Kelly B, Irie Y, Jennings LK, Xu B, Limoli DH, Harrison JJ, Parsek MR, White P, Wozniak DJ. 2014. ChiP-Seq and RNA-Seq reveal an AmrZ-mediated mechanism for cyclic di-GMP synthesis and biofilm development by Pseudomonas aeruginosa. PLoS Pathog 10:e1003984. doi: 10.1371/journal.ppat.1003984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Jones CJ, Ryder CR, Mann EE, Wozniak DJ. 2013. AmrZ modulates Pseudomonas aeruginosa biofilm architecture by directly repressing transcription of the psl operon. J Bacteriol 195:1637–1644. doi: 10.1128/JB.02190-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Ghafoor A, Hay ID, Rehm BHA. 2011. Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl Environ Microbiol 77:5238–5246. doi: 10.1128/AEM.00637-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98. Hou L, Debru A, Chen Q, Bao Q, Li K. 2019. AmrZ regulates swarming motility through cyclic-di-GMP-dependent motility inhibition and controlling Pel polysaccharide production in Pseudomonas aeruginosa PA14. Front Microbiol 10:1847. doi: 10.3389/fmicb.2019.01847 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Evans LR, Linker A. 1973. Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J Bacteriol 116:915–924. doi: 10.1128/jb.116.2.915-924.1973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Wozniak DJ, Wyckoff TJO, Starkey M, Keyser R, Azadi P, O’Toole GA, Parsek MR. 2003. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 100:7907–7912. doi: 10.1073/pnas.1231792100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Friedman L, Kolter R. 2004. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol Microbiol 51:675–690. doi: 10.1046/j.1365-2958.2003.03877.x [DOI] [PubMed] [Google Scholar]
  • 102. Colvin KM, Gordon VD, Murakami K, Borlee BR, Wozniak DJ, Wong GCL, Parsek MR. 2011. The Pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog 7:e1001264. doi: 10.1371/journal.ppat.1001264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Pérez-Mendoza D, Felipe A, Ferreiro MD, Sanjuán J, Gallegos MT. 2019. AmrZ and FleQ co-regulate cellulose production in Pseudomonas syringae pv. Tomato DC3000. Front. Microbiol 10:1–16. doi: 10.3389/fmicb.2019.00746 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104. Ma Y, Zhang Q, Yang Z, Li Y, Yan Y, Ping S, Zhang L, Lin M, Lu W. 2016. Identification of the nitrogen-fixing Pseudomonas stutzeri major flagellar gene regulator FleQ and its role in biofilm formation and root colonization. J. Integr. Agric 15:339–348. doi: 10.1016/S2095-3119(15)61132-7 [DOI] [Google Scholar]
  • 105. Leal-Morales A, Pulido-Sánchez M, López-Sánchez A, Govantes F. 2022. Transcriptional organization and regulation of the Pseudomonas putida flagellar system. Environ Microbiol 24:137–157. doi: 10.1111/1462-2920.15857 [DOI] [PubMed] [Google Scholar]
  • 106. Navarrete B, Leal-Morales A, Serrano-Ron L, Sarrió M, Jiménez-Fernández A, Jiménez-Díaz L, López-Sánchez A, Govantes F. 2019. Transcriptional organization, regulation and functional analysis of flhF and fleN in Pseudomonas putida. PLoS One 14:e0214166. doi: 10.1371/journal.pone.0214166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107. Molina-Henares MA, Ramos-González MI, Daddaoua A, Fernández-Escamilla AM, Espinosa-Urgel M. 2017. FleQ of Pseudomonas putida KT2440 is a multimeric cyclic diguanylate binding protein that differentially regulates expression of biofilm matrix components. Res Microbiol 168:36–45. doi: 10.1016/j.resmic.2016.07.005 [DOI] [PubMed] [Google Scholar]
  • 108. Martínez-Rodríguez L, López-Sánchez A, García-Alcaide A, Govantes F, Gallegos MT. 2023. FleQ, FleN and c-di-GMP coordinately regulate cellulose production in Pseudomonas syringae pv. tomato DC3000. Front Mol Biosci 10:1155579. doi: 10.3389/fmolb.2023.1155579 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109. Jacobi S, Schade R, Heuner K. 2004. Characterization of the alternative sigma factor sigma54 and the transcriptional regulator FleQ of Legionella pneumophila, which are both involved in the regulation cascade of flagellar gene expression. J Bacteriol 186:2540–2547. doi: 10.1128/JB.186.9.2540-2547.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Spohn G, Scarlato V. 1999. Motility of Helicobacter pylori is coordinately regulated by the transcriptional activator FlgR, an NtrC homolog. J Bacteriol 181:593–599. doi: 10.1128/JB.181.2.593-599.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Ramakrishnan G, Newton A. 1990. FlbD of caulobacter crescentus is a homologue of the NtrC (NRI) protein and activates σ54-dependent flagellar gene promoters. Proc Natl Acad Sci USA 87:2369–2373. doi: 10.1073/pnas.87.6.2369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Klose KE, Mekalanos JJ. 1998. Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle. Mol Microbiol 28:501–520. doi: 10.1046/j.1365-2958.1998.00809.x [DOI] [PubMed] [Google Scholar]
  • 113. Srivastava D, Hsieh ML, Khataokar A, Neiditch MB, Waters CM. 2013. Cyclic di-GMP inhibits Vibrio cholerae motility by repressing induction of transcription and inducing extracellular polysaccharide production. Mol Microbiol 90:1262–1276. doi: 10.1111/mmi.12432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Blagotinsek V, Schwan M, Steinchen W, Mrusek D, Hook JC, Rossmann F, Freibert SA, Kratzat H, Murat G, Kressler D, Beckmann R, Beeby M, Thormann KM, Bange G. 2020. An ATP-dependent partner switch links flagellar C-ring assembly with gene expression. Proc Natl Acad Sci USA 117:20826–20835. doi: 10.1073/pnas.2006470117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. McWilliam H, Li W, Uludag M, Squizzato S, Park YM, Buso N, Cowley AP, Lopez R. 2013. Analysis tool web services from the EMBL-EBI. Nucleic Acids Res 41:597–600. doi: 10.1093/nar/gkt376 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES